Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Nexstar Media Group reported record third-quarter net revenue of $2.1 billion, a 78% increase year-over-year, driven by the acquisition of TEGNA, Inc. and record political advertising revenue. The company generated net income of $250 million and Adjusted Free Cash Flow of $443 million, while reducing debt by $1.3 billion year-to-date.
Term
Q3 2026
“Nexstar delivered the highest quarterly net revenue in the Company’s history, reflecting the acquisition of TEGNA, Inc. and strong distribution and advertising revenue performance, including all-time high third-quarter political advertising revenue.”
Perry A. Sook, Founder, Chairman and CEO
“Our strong operating performance for the first nine months of the year generated $1.1 billion in Adjusted Free Cash Flow, enabling us to reduce debt by $786 million and return $171 million to shareholders through dividends, while also funding ongoing investments in local news and sports programming.”
Korsana Biosciences reported third quarter 2026 financial results, highlighting a cash position of $456.2 million following its merger with Cyclerion Therapeutics and a $380 million private placement. The company expects its current capital to fund operations into 2029 as it advances its lead Alzheimer's candidate, KRSA-028, toward Phase 1 clinical data in mid-2027.
Term
Q3 2026
“The third quarter was transformative for Korsana, providing us with the financial resources and experienced leadership team to execute our strategy. With this foundation in place, we remain focused on advancing KRSA-028 toward the clinic and building the body of evidence supporting the program, including through our first preclinical poster at CTAD later this month.”
Jonathan Violin, Ph.D., President and Chief Executive Officer
Core Natural Resources, Inc. filed this Form 10-Q on November 5, 2026, following its formation through the merger of Arch Resources and CONSOL Energy. The report provides quarterly financial results and operational updates for the combined entity's coal production and export activities.
Entrada Therapeutics reported third quarter 2026 financial results and provided updates on its clinical pipeline, including its ELEVATE-44-201 and ELEVATE-45-201 programs for Duchenne muscular dystrophy. The company ended the quarter with $193 million in cash, extending its expected runway into Q4 2027. Multiple clinical data readouts are expected through the first half of 2027, including data from its DM1 partnership with Vertex.
“The October Cohort 1 data from ELEVATE-45-201 marked our third consecutive readout demonstrating encouraging safety and tolerability across our clinical programs. With these initial dose cohorts supporting the safety profile of our lead Duchenne programs, our attention now turns to the next set of readouts designed to further define the potential of our investigational medicines.”
Dipal Doshi, Chief Executive Officer of Entrada Therapeutics
“Including the anticipated Phase 1/2 clinical data from our partner Vertex’s GALILEO study in myotonic dystrophy type 1 during the second half of 2026, we expect four clinical data readouts through the first half of 2027. This marks an important period of clinical catalysts for Entrada as we advance our pipeline and work toward our goal of delivering potentially transformative medicines to people living with serious neuromuscular diseases.”
Dipal Doshi, Chief Executive Officer of Entrada Therapeutics
Resolute Holdings Management reported Q3 2026 financial results, highlighting a significant increase in Non-GAAP Fee-Related Earnings to $0.69 per share compared to $0.13 in the prior year. The company also announced that its board of directors authorized an increase to its share repurchase program to $100.0 million with no expiration date.
Bentley Systems reported third quarter 2026 total revenues of $421.5 million, representing a 12.2% year-over-year increase. The company achieved a constant currency ARR growth rate of 13%, which exceeded its annual outlook range, driven by strength in Resources and Public Works & Utilities sectors.
Term
Q3 2026
“The progression throughout 2026 to date of BSY’s year-over-year ARR growth rate to 13%, exceeding our annual outlook range, reflects both the robustness of our focused end markets, and accounts’ confidence in our mutual trajectories for infrastructure AI.”
Greg Bentley, Executive Chair
“We delivered another quarter of accelerated growth, driven by strength in Resources and continued momentum in Public Works & Utilities. The engineering firms we serve are benefiting from an unprecedented level of investment in infrastructure for AI.”
Commerce.com, Inc. reported Q3 2026 financial results with total revenue of $84.2 million and total ARR of $357.6 million. The company also announced that CFO/COO Daniel Lentz will step down on November 13, 2026, with Tyler Duncan appointed as Interim CFO.
Term
Q3 2026
“Our third quarter results reflect another period of disciplined execution, with total ARR of $357.6 million, 14% GMV growth to $9.0 billion, and $9.4 million in operating cash flow.”
Travis Hess, CEO of Commerce
“Just as important, the strategic operating plan we initiated in September is driving greater efficiency and profitability while protecting investments in our highest-impact growth areas: product intelligence, AI-driven agentic commerce and the open architecture merchants need as commerce becomes increasingly distributed.”
Madison Air Solutions Corp filed a Form 10-Q on November 5, 2026. The provided document snippet contains filing metadata but does not include specific financial highlights, performance metrics, or guidance.
Cartesian Therapeutics reported its third-quarter 2026 results, highlighting continued investment in its mRNA cell therapy pipeline, specifically lead candidate Descartes-08. The company maintained a strong cash position to fund operations into 2027, despite a net loss driven by increased clinical trial expenses.
Core Scientific reported third quarter 2026 financial results, highlighted by a nearly 60% sequential increase in colocation revenue to $215.4 million. The company achieved net income of $1.2 billion, primarily driven by a non-cash gain from the change in fair value of warrants, and significantly expanded its Adjusted EBITDA margins to 57%.
“Our execution at scale is translating into results, with a significant sequential increase in GAAP colocation revenue. We are nearing full delivery under our first colocation agreement while construction under our second is underway across five campuses. With revenue growing and substantial contracted capacity still to deliver, we have built a strong foundation for our next phase of growth.”
Adam Sullivan, Chief Executive Officer of Core Scientific
Brady Corporation entered into a Share Exchange Agreement with William H. Brady III, who exchanged all 1,769,314 of his Class B voting shares for an equal number of newly issued Class A non-voting shares. As a result of the exchange, Director Elizabeth P. Bruno now holds 100% of the Company's Class B Common Stock and sole voting control of the registrant. The newly issued Class A shares are subject to a 24-month lock-up period.
Korro Bio received notice from Novo Nordisk of its election to terminate their 2024 research collaboration and license agreement for convenience, effective February 1, 2027. The partnership, which focused on cardiometabolic targets, had been paused since November 2025 and will now conclude with all licenses terminated and no milestone payments earned.
Counterparty
Novo Nordisk A/S
“Initiating dosing in ANCHOR brings KRRO-121 a meaningful step closer to these patients, and we look forward to dosing participants with UCDs in the first half of 2027. In AATD, our preclinical data showing over 95% correction of the disease-causing transcripts gives us confidence as we prepare KRRO-111 for the clinic. Both programs reflect what our OPERA platform is intended to do: correct disease at the level of RNA, with the precision to generate the protein of interest and convenience of subcutaneous administration. We are focused on execution, with two GalNAc-delivered RNA-editing programs advancing toward clinical data, and a cash runway into the second half of 2028.”
Ram Aiyar, PhD, MBA, Chief Executive Officer and President of Korro Bio
Avalo Therapeutics reported its quarterly financial results for the period ended September 30, 2026, highlighting the continued clinical development of its lead immunology assets. The filing details research and development expenses, net losses, and the company's current liquidity position as it pursues key pipeline milestones.
News Corp reported its quarterly financial results for the period ended September 30, 2026, highlighting performance across its key segments including Dow Jones and Digital Real Estate Services. The filing details consolidated revenues and net income, reflecting ongoing digital transformation and subscription growth strategies.
Core Natural Resources reported Q3 2026 net income of $9.0 million on revenues of $1.1 billion, driven by its thermal and metallurgical coal segments. The company returned $90 million to stockholders during the quarter through share repurchases and dividends, while securing 29.4 million tons of future sales commitments.
“Core continues to demonstrate the power of its highly cash-generative portfolio of world-class assets and its strategic engagement in the most compelling segments of the global marketplace.”
Jimmy Brock, Core’s chairman and CEO
“During Q3, the Core team again generated robust free cash flow and returned a substantial amount of capital to stockholders for the seventh straight quarter.”
Peloton reported Q1 FY2027 financial results with revenue of $559 million, marking its third consecutive quarter of year-over-year growth. The company achieved GAAP net income of $96 million and significantly improved its balance sheet by reducing gross principal debt by 32% during the 2026 calendar year.
Term
Q1 FY2027
“Our Q1 results underscore the strength of our business and reinforce the trajectory of our multi-year transformation. Our purposeful innovation has enabled us to target the multibillion-dollar at-home treadmill market with our best products and broadest price range ever, advance digital personalized training through Peloton IQ, and launch the Peloton Commercial Series to meet Members wherever they train.”
Peter Stern, Peloton's CEO and President
“We began the fiscal year by demonstrating that our financial engine is operating efficiently in the short-term while positioning us for the future. Our performance across the top and bottom lines is testament to our disciplined approach on cost along with continued strong Member engagement and strength in our commercial business.”
ANI Pharmaceuticals reported a significant improvement in financial position for the period ended September 30, 2026, shifting from an accumulated deficit of $23.1 million to retained earnings of $66.3 million. Total assets increased to $1.57 billion, driven by a substantial rise in cash and cash equivalents to $420.8 million, while the company continues to focus on strategic growth through the proposed acquisition of Egetis Therapeutics AB.
Advanced Drainage Systems reported fiscal second quarter 2027 results with net sales increasing 4.6% to $889.4 million. The company also announced a quarterly cash dividend of $0.20 per share and highlighted the proposed acquisition of StormTrap to expand its stormwater solutions portfolio.
“Our second quarter results demonstrate the resilience of our business model and the team's ability to execute in a challenging demand environment. Net sales increased 4.6% to $889.4 million, including the contribution from NDS, and we generated Adjusted EBITDA of $286.8 million, resulting in an Adjusted EBITDA margin of 32.2%.”
Scott Barbour, President and Chief Executive Officer
“We continue to see strong performance in areas where innovation and evolving regulations are creating new demand, with advanced wastewater treatment, stormwater capture and water quality products each growing double digits. We also took an important step to expand our addressable market with the proposed acquisition of StormTrap, a leader in large-volume, space-constrained and highly engineered stormwater solutions.”
Scott Barbour, President and Chief Executive Officer
Wheels Up reported Q3 2026 financial results, highlighting a 44% year-over-year improvement in Adjusted EBITDAR loss to $13.2 million and an inflection point where its Signature fleet revenue surpassed legacy revenue. Alongside the results, the company secured an additional $100 million revolving credit facility from Delta Air Lines to support its ongoing business transformation and fleet investments.
Counterparty
Delta Air Lines, Inc.
Term
through Dec 2027
“The third quarter marked an important inflection point for Wheels Up as the strategic actions we took earlier this year began to translate into stronger commercial and operational performance. Signature revenue and memberships surpassed legacy revenue and memberships for the first time, demand for our premium fleet continued to scale, Adjusted Contribution Margin improved significantly despite transitory headwinds from the wind-down of legacy programs, and we delivered improvement across all operational performance metrics.”
DNOW Inc. reported third quarter 2026 revenue of $1.34 billion and net income of $26 million. The company generated strong operating cash flow of $120 million and continued its capital return program by repurchasing $17 million of common stock during the quarter.
Term
Q3 2026
“Our team delivered another quarter of outstanding execution, generating third quarter Adjusted EBITDA of $76 million, nearly double our first quarter results, reflecting broad-based strength across the company. Sales increased sequentially in all three geographic segments, with solid growth in the downstream, industrial and midstream businesses, with the gas utilities business achieving its highest quarterly revenue in three years.”
David Cherechinsky, President and CEO of DNOW Inc.
“Cash flow from operating activities was incredibly strong at $120 million, fueled by substantial improvements in working capital velocity. As a result, we further strengthened our balance sheet, reducing our net debt leverage ratio to 1.1 times, enhancing our financial flexibility to capitalize on future opportunities.”
David Cherechinsky, President and CEO of DNOW Inc.
ANI Pharmaceuticals reported Q3 2026 net revenues of $290.8 million, a 27.6% year-over-year increase driven by strong performance in its Rare Disease and Generics segments. The company narrowed its full-year revenue guidance and raised its adjusted EBITDA and EPS outlook while highlighting its pending acquisition of Egetis Therapeutics.
Term
Q3 2026
“In the third quarter, ANI delivered strong financial results, while advancing our transformation into a leading Rare Disease company. Cortrophin Gel delivered solid growth, driven by momentum from the gout expansion and continued progress in our existing specialties, while our Generics business continued to outperform.”
Nikhil Lalwani, President and CEO of ANI
“As we head into the end of the year, we are focused on delivering our 2026 financial guidance and advancing the proposed acquisition of Egetis toward closing. We are also executing multiple operational and strategic initiatives to achieve approximately 40% year-over-year growth in 2026 for Cortrophin and capture the significant multi-year growth opportunity ahead.”
Bob’s Discount Furniture reported third quarter 2026 net revenue of $680.4 million, a 10.3% increase year-over-year, driven by 11 new store openings and 3.8% comparable sales growth. Net income rose 28.8% to $41.7 million, aided by $4.9 million in tariff refunds and broad-based expense leverage. The company reaffirmed its full-year 2026 financial outlook while expanding its footprint to 229 stores across 28 states.
Term
Q3 2026
“We delivered another strong quarter, with sales growth, market share gains and margin expansion underscoring the strength and resilience of our model. Customers continue to respond to our combination of everyday value, differentiated products and omnichannel capabilities.”
Bill Barton, President and Chief Executive Officer
Krispy Kreme reported third quarter 2026 financial results, highlighting a GAAP net loss of $13.3 million and net revenue of $328.8 million. The company increased its full-year revenue guidance as it continues a turnaround plan focused on refranchising, margin expansion, and international growth, including a new development agreement for Pakistan.
“We made significant progress on our turnaround in the third quarter, growing systemwide sales through international franchise expansion, reducing leverage, and improving free cash flow compared to last year.”
Josh Charlesworth, CEO
“Our results demonstrate the success of the actions we are taking to drive sustainable, profitable growth and improve profitability, including a significant expansion in Adjusted EBITDA margin of 240 basis points compared to last year when excluding the cyber insurance recovery.”
DTE Energy Divestiture to J.P. Morgan Asset Management for $3B
DTE Energy entered into a definitive agreement to sell its non-utility DTE Vantage business to institutional investors advised by J.P. Morgan Asset Management for approximately $3 billion. The strategic sale allows DTE to focus resources on its regulated electric and gas utilities and support a $44 billion five-year capital investment plan. The transaction is expected to close in the first half of 2027.
Value
$3B
Counterparty
J.P. Morgan Asset Management
“This transaction advances our strategy to focus our resources on our regulated electric and gas utilities, where we see significant opportunities to invest on behalf of customers and communities. The sale supports our plan to deliver meaningful affordability benefits for customers, strengthens our ability to execute a substantial utility investment plan and positions DTE as a high-growth, premium utility with a stronger long-term outlook.”
Lamar Advertising reported Q3 2026 net revenues of $624.5 million, a 6.6% increase year-over-year, driven by national customer demand and political spending. The company raised its full-year 2026 AFFO guidance to a range of $8.87 to $8.97 per diluted share following strong quarterly performance.
Term
Q3 2026
“Our sales growth accelerated in the third quarter, buoyed by demand from national customers, our digital platform and political spend. With those results in hand and a strong start to the fourth quarter, we are raising our guidance for full-year AFFO per diluted share to a range of $8.87 to $8.97.”
Kontoor Brands reported Q3 2026 revenue of $685 million, a 3% increase driven by growth in the Wrangler and Helly Hansen brands. The company successfully completed the divestiture of Lee for $698 million in net proceeds and announced a $400 million accelerated share repurchase program for the fourth quarter.
Term
Q3 2026
“Our third quarter results were driven by growth in both Wrangler and Helly Hansen, strong earnings and gross margin expansion. Execution excellence remains a critical focus of our organization as we delivered strong business results, successfully completed the divestiture of Lee, advanced our integration of Helly Hansen, and realized additional synergies through optimization of our tax platform. Kontoor enters its next chapter as a more focused company anchored around two iconic brands with stronger growth profiles that position us well for the future.”
Scott Baxter, Chief Executive Officer and Chairman of the Board of Directors
“We are building a more growth-oriented business through our transformation efforts and the evolution of our portfolio. These efforts are enabling us to attract top-tier talent, create investment capacity and enhance organizational agility, positioning us well to win in any environment. We have increased our planned share repurchases to $450 million based on the confidence we have in our long-term strategy and the significant value-creation opportunity ahead. Based on our year-to-date results and the optionality of our model, we are raising our full year earnings outlook.”
Joe Alkire, Kontoor Brands’ President and Chief Financial Officer
Virtu Financial reported third quarter 2026 results with total revenues of $1,153.9 million and net income of $282.5 million, driven by a 55% increase in net trading income. The company also announced a quarterly dividend of $0.24 per share and a plan to reincorporate from Delaware to Texas following approval by its majority shareholder.
Brilliant Earth Group reported Q3 2026 financial results with net sales of $112.8 million, a 2.3% year-over-year increase that exceeded company guidance. The company achieved a record gross margin of 59.7% and returned to GAAP profitability with net income of $2.4 million, driven by strong performance in fine jewelry and wedding band bookings.
Term
Q3 2026
“We're pleased with our third quarter results, with both Net Sales and Adjusted EBITDA exceeding our guidance. Our team's ability to drive top line growth, expand gross margin and manage expenses with discipline reflects the consistent execution that sets Brilliant Earth apart.”
Beth Gerstein, Co-Founder and Chief Executive Officer
Eos Energy Enterprises reported a significant increase in total revenue to $208.5 million for the nine months ended September 30, 2026, compared to $56.2 million in the prior year, largely driven by related party transactions. Despite an operating loss of $242.4 million, the company achieved a net income applicable to common stock of $1.24 billion due to substantial non-cash gains from the change in fair value of derivatives and warrants.
Cardinal Health reported Q1 fiscal 2027 revenue of $67.5 billion, a 5% increase year-over-year, driven by brand and specialty pharmaceutical sales. Non-GAAP diluted EPS rose 28% to $3.26, leading the company to raise its full-year fiscal 2027 non-GAAP EPS guidance. The company also completed a $500 million share repurchase program during the quarter.
Term
Q1 2027
“Our results reflect a strong start to fiscal 2027 and demonstrate consistent execution against our strategic priorities. We continue to benefit from focused investments, disciplined operations and the strength of our diversified portfolio. Given this quarter's strong performance and our updated expectations for the remainder of the year, we are raising our fiscal 2027 non-GAAP EPS outlook.”